MMDA-2

MMDA-2
Clinical data
Other names	2-Methoxy-4,5-methylenedioxyamphetamine; 6-Methoxy-3,4-methylenedioxyamphetamine; 6-Methoxy-MDA; 6-MeO-MDA
Routes of; administration	Oral
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class A; Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries);
Pharmacokinetic data
Duration of action	8–12 hours
Identifiers
	IUPAC name 1-(6-methoxy-1,3-benzodioxol-5-yl)propan-2-amine;
CAS Number	23693-18-7;
PubChem CID	90966;
ChemSpider	82147;
UNII	TG0B6ER184;
CompTox Dashboard (EPA)	DTXSID20903968 ;
Chemical and physical data
Formula	C11H15NO3
Molar mass	209.245 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O1c2cc(c(OC)cc2OC1)CC(N)C;

MMDA-2, also known as 2-methoxy-4,5-methylenedioxyamphetamine or as 6-methoxy-MDA, is a psychedelic drug of the phenethylamine, amphetamine, and MDxx families. It is the 6-methoxy derivative of MDA and is a positional isomer of MMDA (5-methoxy-MDA).